Metabonomic profiling of bladder cancer

Journal of Proteome Research

Volumn 14, Issue 2, 2015, Pages 587-602

  Chan, Eric Chun Yong ^a   Pasikanti, Kishore Kumar ^a   Hong, Yanjun ^a   Ho, Paul C ^a   Mahendran, Ratha ^b   Raman Nee Mani, Lata ^b   Chiong, Edmund ^b   Esuvaranathan, Kesavan ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

biomarker; bladder cancer; GC MS; LC MS; metabonomics; NMR

Indexed keywords

BIOLOGICAL MARKER;

BLADDER CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SURVIVAL; CHEMOMETRIC ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTOSCOPY; DERIVATIZATION; DISEASE SURVEILLANCE; EARLY DIAGNOSIS; GENE EXPRESSION; HUMAN; LONG TERM SURVIVAL; METABOLITE; PREDICTION; PRIORITY JOURNAL; PYRIMIDINE METABOLISM; REVIEW; TRYPTOPHAN METABOLISM; BLADDER TUMOR; METABOLISM; METABOLOMICS; PATHOLOGY;

HUMANS; METABOLOMICS; URINARY BLADDER NEOPLASMS;

EID: 84922655483     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr500966h     Document Type: Review

References (196)

1. Siegel, R.; Naishadham, D.; Jemal, A. Cancer statistics, 2012 Ca-Cancer J. Clin. 2012, 62 (1) 10-29
2. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Thun, M. J. Cancer statistics, 2009 Ca-Cancer J. Clin. 2009, 59 (4) 225-249
3. Mitra, A. P.; Cote, R. J. Molecular pathogenesis and diagnostics of bladder cancer Annu. Rev. Pathol. 2009, 4, 251-285
4. Kaufman, D. S.; Shipley, W. U.; Feldman, A. S. Bladder cancer Lancet 2009, 374 (9685) 239-249
5. Ruder, A. M.; Fine, L. J.; Sundin, D. S. National estimates of occupational exposure to animal bladder tumorigens J. Occup. Med. 1990, 32 (9) 797-805
6. Pelucchi, C.; Bosetti, C.; Negri, E.; Malvezzi, M.; La Vecchia, C. Mechanisms of disease: The epidemiology of bladder cancer Nat. Clin. Pract. Urol. 2006, 3 (6) 327-340
7. Castelao, J. E.; Yuan, J. M.; Gago-Dominguez, M.; Yu, M. C.; Ross, R. K. Non-steroidal anti-inflammatory drugs and bladder cancer prevention Br. J. Cancer 2000, 82 (7) 1364-1369
8. Marcus, P. M.; Vineis, P.; Rothman, N. NAT2 slow acetylation and bladder cancer risk: a meta-analysis of 22 case-control studies conducted in the general population Pharmacogenetics 2000, 10 (2) 115-122
9. Mitra, A. P.; Cote, R. J. Molecular screening for bladder cancer: progress and potential Nat. Rev. Urol. 2010, 7 (1) 11-20
10. Hurle, R.; Losa, A.; Manzetti, A.; Lembo, A. Upper urinary tract tumors developing after treatment of superficial bladder cancer: 7-year follow-up of 591 consecutive patients Urology 1999, 53 (6) 1144-1148
11. Wu, X. R. Urothelial tumorigenesis: a tale of divergent pathways Nat. Rev. Cancer 2005, 5 (9) 713-725
12. Steinberg, G. D.; Trump, D. L.; Cummings, K. B. Metastatic bladder cancer. Natural history, clinical course, and consideration for treatment Urol. Clin. North Am. 1992, 19 (4) 735-746
13. Alexandroff, A. B.; Jackson, A. M.; O'Donnell, M. A.; James, K. BCG immunotherapy of bladder cancer: 20 years on Lancet 1999, 353 (9165) 1689-1694
14. Sharma, S.; Ksheersagar, P.; Sharma, P. Diagnosis and treatment of bladder cancer Am. Fam. Physician 2009, 80 (7) 717-723
15. Cookson, M. S.; Herr, H. W.; Zhang, Z. F.; Soloway, S.; Sogani, P. C.; Fair, W. R. The treated natural history of high risk superficial bladder cancer: 15-year outcome J. Urol. 1997, 158 (1) 62-67
16. Babjuk, M.; Oosterlinck, W.; Sylvester, R.; Kaasinen, E.; Bohle, A.; Palou-Redorta, J. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder Eur. Urol. 2008, 54 (2) 303-314
17. Lokeshwar, V. B.; Habuchi, T.; Grossman, H. B.; Murphy, W. M.; Hautmann, S. H.; Hemstreet, G. P., 3rd; Bono, A. V.; Getzenberg, R. H.; Goebell, P.; Schmitz-Drager, B. J.; Schalken, J. A.; Fradet, Y.; Marberger, M.; Messing, E.; Droller, M. J. Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers Urology 2005, 66 (6 Suppl 1) 35-63
18. James, A. C.; Gore, J. L. The costs of non-muscle invasive bladder cancer Urol. Clin. North Am. 2013, 40 (2) 261-269
19. Hansen, R. P.; Vedsted, P.; Sokolowski, I.; Sondergaard, J.; Olesen, F. Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patients BMC Health Serv. Res. 2011, 11, 284
20. Knowles, M. A. Molecular pathogenesis of bladder cancer Int. J. Clin. Oncol. 2008, 13 (4) 287-297
21. Lacy, S.; Lopez-Beltran, A.; MacLennan, G. T.; Foster, S. R.; Montironi, R.; Cheng, L. Molecular pathogenesis of urothelial carcinoma: the clinical utility of emerging new biomarkers and future molecular classification of bladder cancer Anal. Quant. Cytol. Histol. 2009, 31 (1) 5-16
22. Vriesema, J. L.; Poucki, M. H.; Kiemeney, L. A.; Witjes, J. A. Patient opinion of urinary tests versus flexible urethrocystoscopy in follow-up examination for superficial bladder cancer: a utility analysis Urology 2000, 56 (5) 793-797
23. Wishart, D. S.; Jewison, T.; Guo, A. C.; Wilson, M.; Knox, C.; Liu, Y.; Djoumbou, Y.; Mandal, R.; Aziat, F.; Dong, E.; Bouatra, S.; Sinelnikov, I.; Arndt, D.; Xia, J.; Liu, P.; Yallou, F.; Bjorndahl, T.; Perez-Pineiro, R.; Eisner, R.; Allen, F.; Neveu, V.; Greiner, R.; Scalbert, A. HMDB 3.0 - The Human Metabolome Database in 2013 Nucleic Acids Res. 2013, 41 (Database issue) D801-D807
24. Nicholson, J. K.; Lindon, J. C.; Holmes, E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data Xenobiotica 1999, 29 (11) 1181-1189
25. Fiehn, O. Metabolomics - the link between genotypes and phenotypes Plant Mol. Biol. 2002, 48 (1-2) 155-171
26. ter Kuile, B. H.; Westerhoff, H. V. Transcriptome meets metabolome: hierarchical and metabolic regulation of the glycolytic pathway FEBS Lett. 2001, 500 (3) 169-171
27. Griffin, J. L.; Shockcor, J. P. Metabolic profiles of cancer cells Nat. Rev. Cancer 2004, 4 (7) 551-561
28. Kaddurah-Daouk, R.; Kristal, B. S.; Weinshilboum, R. M. Metabolomics: a global biochemical approach to drug response and disease Annu. Rev. Pharmacol. Toxicol. 2008, 48, 653-683
29. Martin, F. P.; Dumas, M. E.; Wang, Y.; Legido-Quigley, C.; Yap, I. K.; Tang, H.; Zirah, S.; Murphy, G. M.; Cloarec, O.; Lindon, J. C.; Sprenger, N.; Fay, L. B.; Kochhar, S.; van Bladeren, P.; Holmes, E.; Nicholson, J. K. A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model Mol. Syst. Biol. 2007, 3, 112
30. Schnackenberg, L. K.; Beger, R. D. Metabolomic biomarkers: their role in the critical path Drug Discovery Today: Technol. 2007, 4 (1) 13-16
31. Kind, T.; Tolstikov, V.; Fiehn, O.; Weiss, R. H. A comprehensive urinary metabolomic approach for identifying kidney cancerr Anal. Biochem. 2007, 363 (2) 185-195
32. Yang, Y.; Li, C.; Nie, X.; Feng, X.; Chen, W.; Yue, Y.; Tang, H.; Deng, F. Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning 1H NMR spectroscopy in conjunction with multivariate data analysis J. Proteome Res. 2007, 6 (7) 2605-2614
33. Bathen, T. F.; Jensen, L. R.; Sitter, B.; Fjösne, H. E.; Halgunset, J.; Axelson, D. E.; Gribbestad, I. S.; Lundgren, S. MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status Breast Cancer Res. Treat. 2007, 104 (2) 181-189
34. Serkova, N. J.; Gamito, E. J.; Jones, R. H.; O'Donnell, C.; Brown, J. L.; Green, S.; Sullivan, H.; Hedlund, T.; Crawford, E. D. The metabolites citrate, myo-inositol, and spermine are potential age-independent markers of prostate cancer in human expressed prostatic secretions Prostate 2008, 68 (6) 620-628
35. Denkert, C.; Budczies, J.; Kind, T.; Weichert, W.; Tablack, P.; Sehouli, J.; Niesporek, S.; Könsgen, D.; Dietel, M.; Fiehn, O. Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors Cancer Res. 2006, 66 (22) 10795-10804
36. Michell, A.; Mosedale, D.; Grainger, D.; Barker, R. Metabolomic analysis of urine and serum in Parkinson's disease Metabolomics 2008, 4, 191-201
37. Holmes, E.; Tsang, T. M.; Huang, J. T. J.; Leweke, F. M.; Koethe, D.; Gerth, C. W.; Nolden, B. M.; Gross, S.; Schreiber, D.; Nicholson, J. K.; Bahn, S. Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia PLoS Med. 2006, 3 (8) e327
38. Wood, P. L. Mass Spectrometry Strategies for Clinical Metabolomics and Lipidomics in Psychiatry, Neurology, and Neuro-Oncology Neuropsychopharmacology 2014, 39 (1) 24-33
39. Greenberg, N.; Grassano, A.; Thambisetty, M.; Lovestone, S.; Legido-Quigley, C. A proposed metabolic strategy for monitoring disease progression in Alzheimer's disease Electrophoresis 2009, 30 (7) 1235-1239
40. Ahmed, S. S.; Santosh, W.; Kumar, S.; Christlet, H. T. T. Metabolic profiling of Parkinson's disease: evidence of biomarker from gene expression analysis and rapid neural network detection J. Biomed. Sci. 2009, 16, 63
41. Heather, L. C.; Wang, X.; West, J. A.; Griffin, J. L. A practical guide to metabolomic profiling as a discovery tool for human heart disease J. Mol. Cell. Cardiol. 2013, 55, 2-11
42. Sabatine, M. S.; Liu, E.; Morrow, D. A.; Heller, E.; McCarroll, R.; Wiegand, R.; Berriz, G. F.; Roth, F. P.; Gerszten, R. E. Metabolomic identification of novel biomarkers of myocardial ischemia Circulation 2005, 112 (25) 3868-3875
43. Weiss, R. H.; Kim, K. Metabolomics in the study of kidney diseases. Nature reviews Nephrology 2012, 8 (1) 22-33
44. Zeng, M.; Che, Z.; Liang, Y.; S, M. GC-Plasma Metabolic Profiling of Type 2 Diabetes Mellitus Dis. Markers 2009, 69, 941-948
45. Yang, J.; Xu, G.; Hong, Q.; Liebich, H. M.; Lutz, K.; Schmülling, R. M.; Wahl, H. G. Discrimination of Type 2 diabetic patients from healthy controls by using metabonomics method based on their serum fatty acid profiles J. Chromatogr., B 2004, 813 (1-2) 53-58
46. Yi, L.-Z.; He, J.; Liang, Y.-Z.; Yuan, D.-L.; Chau, F.-T. Plasma fatty acid metabolic profiling and biomarkers of type 2 diabetes mellitus based on GC/MS and PLS-LDA FEBS Lett. 2006, 580 (30) 6837-6845
47. Yuan, K.; Kong, H.; Guan, Y.; Yang, J.; Xu, G. A GC-based metabonomics investigation of type 2 diabetes by organic acids metabolic profile J. Chromatogr., B 2007, 850 (1-2) 236-240
48. Tenori, L.; Oakman, C.; Claudino, W. M.; Bernini, P.; Cappadona, S.; Nepi, S.; Biganzoli, L.; Arbushites, M. C.; Luchinat, C.; Bertini, I.; Di Leo, A. Exploration of serum metabolomic profiles and outcomes in women with metastatic breast cancer: a pilot study Mol. Oncol. 2012, 6 (4) 437-444
49. Shah, A. A.; Craig, D. M.; Sebek, J. K.; Haynes, C.; Stevens, R. C.; Muehlbauer, M. J.; Granger, C. B.; Hauser, E. R.; Newby, L. K.; Newgard, C. B.; Kraus, W. E.; Hughes, G. C.; Shah, S. H. Metabolic profiles predict adverse events after coronary artery bypass grafting J. Thorac. Cardiovasc. Surg. 2012, 143 (4) 873-878
50. Wang, T. J.; Larson, M. G.; Vasan, R. S.; Cheng, S.; Rhee, E. P.; McCabe, E.; Lewis, G. D.; Fox, C. S.; Jacques, P. F.; Fernandez, C.; O'Donnell, C. J.; Carr, S. A.; Mootha, V. K.; Florez, J. C.; Souza, A.; Melander, O.; Clish, C. B.; Gerszten, R. E. Metabolite profiles and the risk of developing diabetes Nat. Med. 2011, 17 (4) 448-453
51. Roberts, L. D.; Gerszten, R. E. Toward New Biomarkers of Cardiometabolic Diseases Cell Metab. 2013, 18 (1) 43-50
52. Trock, B. J. Application of metabolomics to prostate cancer Urol. Oncol. 2011, 29 (5) 572-581
53. Sreekumar, A.; Poisson, L. M.; Rajendiran, T. M.; Khan, A. P.; Cao, Q.; Yu, J.; Laxman, B.; Mehra, R.; Lonigro, R. J.; Li, Y.; Nyati, M. K.; Ahsan, A.; Kalyana-Sundaram, S.; Han, B.; Cao, X.; Byun, J.; Omenn, G. S.; Ghosh, D.; Pennathur, S.; Alexander, D. C.; Berger, A.; Shuster, J. R.; Wei, J. T.; Varambally, S.; Beecher, C.; Chinnaiyan, A. M. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression Nature 2009, 457 (7231) 910-914
54. Giskeodegard, G. F.; Bertilsson, H.; Selnaes, K. M.; Wright, A. J.; Bathen, T. F.; Viset, T.; Halgunset, J.; Angelsen, A.; Gribbestad, I. S.; Tessem, M. B. Spermine and citrate as metabolic biomarkers for assessing prostate cancer aggressiveness PloS One 2013, 8 (4) e62375
55. Clayton, T. A.; Lindon, J. C.; Cloarec, O.; Antti, H.; Charuel, C.; Hanton, G.; Provost, J. P.; Le Net, J. L.; Baker, D.; Walley, R. J.; Everett, J. R.; Nicholson, J. K. Pharmaco-metabonomic phenotyping and personalized drug treatment Nature 2006, 440 (7087) 1073-1077
56. Nicholson, J. K.; Holmes, E.; Kinross, J. M.; Darzi, A. W.; Takats, Z.; Lindon, J. C. Metabolic phenotyping in clinical and surgical environments Nature 2012, 491 (7424) 384-392
57. Assfalg, M.; Bertini, I.; Colangiuli, D.; Luchinat, C.; Schafer, H.; Schutz, B.; Spraul, M. Evidence of different metabolic phenotypes in humans Proc. Natl. Acad. Sci. U. S. A. 2008, 105 (5) 1420-1424
58. Trygg, J.; Holmes, E.; Lundstedt, T. Chemometrics in metabonomics J. Proteome Res. 2007, 6 (2) 469-479
59. Pasikanti, K. K.; Esuvaranathan, K.; Hong, Y.; Ho, P. C.; Mahendran, R.; Raman Nee Mani, L.; Chiong, E.; Chan, E. C. Y. Urinary metabotyping of bladder cancer using two-dimensional gas chromatography time-of-flight mass spectrometry J. Proteome Res. 2013, 12 (9) 3865-3873
60. Lotan, Y.; Shariat, S. F.; Schmitz-Drager, B. J.; Sanchez-Carbayo, M.; Jankevicius, F.; Racioppi, M.; Minner, S. J.; Stohr, B.; Bassi, P. F.; Grossman, H. B. Considerations on implementing diagnostic markers into clinical decision making in bladder cancer Urol. Oncol. 2010, 28 (4) 441-448
61. Lauridsen, M.; Hansen, S. H.; Jaroszewski, J. W.; Cornett, C. Human urine as test material in 1H NMR-based metabonomics: recommendations for sample preparation and storage Anal. Chem. 2007, 79 (3) 1181-1186
62. Garcia-Villalba, R.; Carrasco-Pancorbo, A.; Nevedomskaya, E.; Mayboroda, O. A.; Deelder, A. M.; Segura-Carretero, A.; Fernandez-Gutierrez, A. Exploratory analysis of human urine by LC-ESI-TOF MS after high intake of olive oil: understanding the metabolism of polyphenols Anal. Bioanal. Chem. 2010, 398 (1) 463-475
63. Fernández-Peralbo, M. A.; Luque de Castro, M. D. Preparation of urine samples prior to targeted or untargeted metabolomics mass-spectrometry analysis Trends Anal. Chem. 2012, 41 (0) 75-85
64. Wang, X.; Lv, H.; Zhang, G.; Sun, W.; Zhou, D.; Jiao, G.; Yu, Y. Development and validation of a ultra performance LC-ESI/MS method for analysis of metabolic phenotypes of healthy men in day and night urine samples J. Sep. Sci. 2008, 31 (16-17) 2994-3001
65. Pasikanti, K. K.; Ho, P. C.; Chan, E. C. Gas chromatography/mass spectrometry in metabolic profiling of biological fluids J. Chromatogr., B 2008, 871 (2) 202-211
66. Walsh, M. C.; Brennan, L.; Malthouse, J. P.; Roche, H. M.; Gibney, M. J. Effect of acute dietary standardization on the urinary, plasma, and salivary metabolomic profiles of healthy humans Am. J. Clin. Nutr. 2006, 84 (3) 531-539
67. Gika, H. G.; Theodoridis, G. A.; Wilson, I. D. Liquid chromatography and ultra-performance liquid chromatography-mass spectrometry fingerprinting of human urine: sample stability under different handling and storage conditions for metabonomics studies J. Chromatogr., A 2008, 1189 (1-2) 314-322
68. Dunn, W. B.; Broadhurst, D.; Ellis, D. I.; Brown, M.; Halsall, A.; O'Hagan, S.; Spasic, I.; Tseng, A.; Kell, D. B. A GC-TOF-MS study of the stability of serum and urine metabolomes during the UK Biobank sample collection and preparation protocols Int. J. Epidemiol. 2008, 37 (Suppl 1) i23-i30
69. Pasikanti, K. K.; Ho, P. C.; Chan, E. C. Development and validation of a gas chromatography/mass spectrometry metabonomic platform for the global profiling of urinary metabolites Rapid Commun. Mass Spectrom. 2008, 22 (19) 2984-2992
70. Dunn, W. B.; Broadhurst, D.; Begley, P.; Zelena, E.; Francis-McIntyre, S.; Anderson, N.; Brown, M.; Knowles, J. D.; Halsall, A.; Haselden, J. N. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry Nat. Protoc. 2011, 6 (7) 1060-1083
71. Xiayan, L.; Legido-Quigley, C. Advances in separation science applied to metabonomics Electrophoresis 2008, 29 (18) 3724-3736
72. Lenz, E. M.; Wilson, I. D. Analytical strategies in metabonomics J. Proteome Res. 2007, 6 (2) 443-458
73. Beckonert, O.; Keun, H. C.; Ebbels, T. M.; Bundy, J.; Holmes, E.; Lindon, J. C.; Nicholson, J. K. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts Nat. Protoc. 2007, 2 (11) 2692-2703
74. Tkac, I.; Henry, P. G.; Zacharoff, L.; Wedel, M.; Gong, W.; Deelchand, D. K.; Li, T.; Dubinsky, J. M. Homeostatic adaptations in brain energy metabolism in mouse models of Huntington disease J. Cereb. Blood Flow Metab. 2012, 32 (11) 1977-1988
75. Atherton, H. J.; Bailey, N. J.; Zhang, W.; Taylor, J.; Major, H.; Shockcor, J.; Clarke, K.; Griffin, J. L. A combined 1H-NMR spectroscopy- and mass spectrometry-based metabolomic study of the PPAR-alpha null mutant mouse defines profound systemic changes in metabolism linked to the metabolic syndrome Physiol. Genomics 2006, 27 (2) 178-186
76. Allwood, J. W.; Erban, A.; de Koning, S.; Dunn, W. B.; Luedemann, A.; Lommen, A.; Kay, L.; Loscher, R.; Kopka, J.; Goodacre, R. Inter-laboratory reproducibility of fast gas chromatography-electron impact-time of flight mass spectrometry (GC-EI-TOF/MS) based plant metabolomics Metabolomics 2009, 5 (4) 479-496
77. Koek, M. M.; Muilwijk, B.; van der Werf, M. J.; Hankemeier, T. Microbial metabolomics with gas chromatography/mass spectrometry Anal. Chem. 2006, 78 (4) 1272-1281
78. Want, E. J.; Nordstrom, A.; Morita, H.; Siuzdak, G. From exogenous to endogenous: the inevitable imprint of mass spectrometry in metabolomics J. Proteome Res. 2007, 6 (2) 459-468
79. Bergeron, A.; Garofolo, F. Importance of matrix effects in LC-MS/MS bioanalysis Bioanalysis 2013, 5 (19) 2331-2332
80. Halket, J. M.; Waterman, D.; Przyborowska, A. M.; Patel, R. K.; Fraser, P. D.; Bramley, P. M. Chemical derivatization and mass spectral libraries in metabolic profiling by GC/MS and LC/MS/MS J. Exp. Bot. 2005, 56 (410) 219-243
81. Metz, T. O.; Zhang, Q.; Page, J. S.; Shen, Y.; Callister, S. J.; Jacobs, J. M.; Smith, R. D. The future of liquid chromatography-mass spectrometry (LC-MS) in metabolic profiling and metabolomic studies for biomarker discovery Biomarkers Med. 2007, 1 (1) 159-185
82. Dunn, W. B.; Ellis, D. I. Metabolomics: current analytical platforms and methodologies Trends Anal. Chem. 2005, 24 (4) 285-294
83. Chambers, E.; Wagrowski-Diehl, D. M.; Lu, Z.; Mazzeo, J. R. Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analyses J. Chromatogr., B 2007, 852 (1-2) 22-34
84. Wishart, D. S.; Lewis, M. J.; Morrissey, J. A.; Flegel, M. D.; Jeroncic, K.; Xiong, Y.; Cheng, D.; Eisner, R.; Gautam, B.; Tzur, D.; Sawhney, S.; Bamforth, F.; Greiner, R.; Li, L. The human cerebrospinal fluid metabolome J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2008, 871 (2) 164-173
85. Dunn, W. B.; Bailey, N. J. C.; Johnson, H. E. Measuring the metabolome: current analytical technologies Analyst 2005, 130 (5) 606-625
86. Chan, E. C.; Pasikanti, K. K.; Nicholson, J. K. Global urinary metabolic profiling procedures using gas chromatography-mass spectrometry Nat. Protoc. 2011, 6 (10) 1483-1499
87. Chan, E. C.; Koh, P. K.; Mal, M.; Cheah, P. Y.; Eu, K. W.; Backshall, A.; Cavill, R.; Nicholson, J. K.; Keun, H. C. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS) J. Proteome Res. 2009, 8 (1) 352-361
88. Emwas, A.-H. M.; Salek, R. M.; Griffin, J. L.; Merzaban, J. NMR-based metabolomics in human disease diagnosis: applications, limitations, and recommendations Metabolomics 2013, 9 (5) 1048-1072
89. Beckonert, O.; Keun, H. C.; Ebbels, T. M.; Bundy, J.; Holmes, E.; Lindon, J. C.; Nicholson, J. K. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts Nat. Protoc. 2007, 2 (11) 2692-2703
90. Want, E. J.; Wilson, I. D.; Gika, H.; Theodoridis, G.; Plumb, R. S.; Shockcor, J.; Holmes, E.; Nicholson, J. K. Global metabolic profiling procedures for urine using UPLC-MS Nat. Protoc. 2010, 5 (6) 1005-1018
91. Theodoridis, G.; Gika, H. G.; Wilson, I. D. LC-MS-based methodology for global metabolite profiling in metabonomics/metabolomics TrAC TrAC, Trends Anal. Chem. 2008, 27 (3) 251-260
92. Vuckovic, D. Current trends and challenges in sample preparation for global metabolomics using liquid chromatography-mass spectrometry Anal. Bioanal. Chem. 2012, 403 (6) 1523-1548
93. Kim, H. K.; Choi, Y. H.; Verpoorte, R. NMR-based metabolomic analysis of plants Nat. Protoc. 2010, 5 (3) 536-549
94. Zhou, B.; Xiao, J. F.; Tuli, L.; Ressom, H. W. LC-MS-based metabolomics Mol. Biosyst. 2012, 8 (2) 470-481
95. Jonsson, P.; Johansson, A. I.; Gullberg, J.; Trygg, J.; A, J.; Grung, B.; Marklund, S.; Sjostrom, M.; Antti, H.; Moritz, T. High-throughput data analysis for detecting and identifying differences between samples in GC/MS-based metabolomic analyses Anal. Chem. 2005, 77 (17) 5635-5642
96. Goodacre, R.; Broadhurst, D.; Smilde, A. K.; Kristal, B. S.; Baker, J. D.; Beger, R.; Bessant, C.; Connor, S.; Calmani, G.; Craig, A.; Ebbels, T.; Kell, D. B.; Manetti, C.; Newton, J.; Paternostro, G.; Somorjai, R.; Sjostrom, M.; Trygg, J.; Wulfert, F. Proposed minimum reporting standards for data analysis in metabolomics Metabolomics 2007, 3 (3) 231-241
97. Katajamaa, M.; Miettinen, J.; Oresic, M. MZmine: toolbox for processing and visualization of mass spectrometry based molecular profile data Bioinformatics 2006, 22 (5) 634-636
98. Smith, C. A.; Want, E. J.; O'Maille, G.; Abagyan, R.; Siuzdak, G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification Anal. Chem. 2006, 78 (3) 779-787
99. Lommen, A. MetAlign: interface-driven, versatile metabolomics tool for hyphenated full-scan mass spectrometry data preprocessing Anal. Chem. 2009, 81 (8) 3079-3086
100. Baran, R.; Kochi, H.; Saito, N.; Suematsu, M.; Soga, T.; Nishioka, T.; Robert, M.; Tomita, M. MathDAMP: a package for differential analysis of metabolite profiles BMC Bioinf. 2006, 7, 530
101. Duran, A. L.; Yang, J.; Wang, L.; Sumner, L. W. Metabolomics spectral formatting, alignment and conversion tools (MSFACTs) Bioinformatics 2003, 19 (17) 2283-2293
102. Eriksson, L.; Umetrics AB. Multi- And Megavariate Data Analysis, 2 nd ed.; Umetrics AB: Umeå, Sweden, 2006.
103. Heather, L. C.; Wang, X.; West, J. A.; Griffin, J. L. A practical guide to metabolomic profiling as a discovery tool for human heart disease J. Mol. Cell. Cardiol. 2013, 55, 2-11
104. Wiklund, S.; Johansson, E.; Sjostrom, L.; Mellerowicz, E. J.; Edlund, U.; Shockcor, J. P.; Gottfries, J.; Moritz, T.; Trygg, J. Visualization of GC/TOF-MS-Based Metabolomics Data for Identification of Biochemically Interesting Compounds Using OPLS Class Models Anal. Chem. 2008, 80 (1) 115-122
105. Madsen, R.; Lundstedt, T.; Trygg, J. Chemometrics in metabolomics - a review in human disease diagnosis Anal. Chim. Acta 2010, 659 (1-2) 23-33
106. Xia, J.; Mandal, R.; Sinelnikov, I. V.; Broadhurst, D.; Wishart, D. S. MetaboAnalyst 2.0-a comprehensive server for metabolomic data analysis Nucleic Acids Res. 2012, 40 (W1) W127-W133
107. Mahadevan, S.; Shah, S. L.; Marrie, T. J.; Slupsky, C. M. Analysis of metabolomic data using support vector machines Anal. Chem. 2008, 80 (19) 7562-7570
108. Broadhurst, D.; Kell, D. Statistical strategies for avoiding false discoveries in metabolomics and related experiments Metabolomics 2006, 2 (4) 171-196
109. Pasikanti, K. K.; Esuvaranathan, K.; Ho, P. C.; Mahendran, R.; Kamaraj, R.; Wu, Q. H.; Chiong, E.; Chan, E. C. Y. Noninvasive urinary metabonomic diagnosis of human bladder cancer J. Proteome Res. 2010, 9 (6) 2988-2995
110. Kopka, J.; Schauer, N.; Krueger, S.; Birkemeyer, C.; Usadel, B.; Bergmuller, E.; Dormann, P.; Weckwerth, W.; Gibon, Y.; Stitt, M.; Willmitzer, L.; Fernie, A. R.; Steinhauser, D. GMD@CSB.DB: the Golm Metabolome Database Bioinformatics 2005, 21 (8) 1635-1638
111. Kind, T.; Wohlgemuth, G.; Lee do, Y.; Lu, Y.; Palazoglu, M.; Shahbaz, S.; Fiehn, O. FiehnLib: mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography/mass spectrometry Anal. Chem. 2009, 81 (24) 10038-10048
112. Ausloos, P.; Clifton, C. L.; Lias, S. G.; Mikaya, A. I.; Stein, S. E.; Tchekhovskoi, D. V.; Sparkman, O. D.; Zaikin, V.; Zhu, D. The critical evaluation of a comprehensive mass spectral library J. Am. Soc. Mass Spectrom. 1999, 10 (4) 287-299
113. Tautenhahn, R.; Cho, K.; Uritboonthai, W.; Zhu, Z.; Patti, G. J.; Siuzdak, G. An accelerated workflow for untargeted metabolomics using the METLIN database Nat. Biotechnol. 2012, 30 (9) 826-828
114. Horai, H.; Arita, M.; Kanaya, S.; Nihei, Y.; Ikeda, T.; Suwa, K.; Ojima, Y.; Tanaka, K.; Tanaka, S.; Aoshima, K.; Oda, Y.; Kakazu, Y.; Kusano, M.; Tohge, T.; Matsuda, F.; Sawada, Y.; Hirai, M. Y.; Nakanishi, H.; Ikeda, K.; Akimoto, N.; Maoka, T.; Takahashi, H.; Ara, T.; Sakurai, N.; Suzuki, H.; Shibata, D.; Neumann, S.; Iida, T.; Tanaka, K.; Funatsu, K.; Matsuura, F.; Soga, T.; Taguchi, R.; Saito, K.; Nishioka, T. MassBank: a public repository for sharing mass spectral data for life sciences J. Mass. Spectrom. 2010, 45 (7) 703-714
115. Sud, M.; Fahy, E.; Cotter, D.; Brown, A.; Dennis, E. A.; Glass, C. K.; Merrill, A. H., Jr.; Murphy, R. C.; Raetz, C. R.; Russell, D. W.; Subramaniam, S. LMSD: LIPID MAPS structure database Nucleic Acids Res. 2007, 35 (Database issue) D527-D532
116. Cui, Q.; Lewis, I. A.; Hegeman, A. D.; Anderson, M. E.; Li, J.; Schulte, C. F.; Westler, W. M.; Eghbalnia, H. R.; Sussman, M. R.; Markley, J. L. Metabolite identification via the Madison Metabolomics Consortium Database Nat. Biotechnol. 2008, 26 (2) 162-64
117. Wishart, D. S.; Tzur, D.; Knox, C.; Eisner, R.; Guo, A. C.; Young, N.; Cheng, D.; Jewell, K.; Arndt, D.; Sawhney, S.; Fung, C.; Nikolai, L.; Lewis, M.; Coutouly, M. A.; Forsythe, I.; Tang, P.; Shrivastava, S.; Jeroncic, K.; Stothard, P.; Amegbey, G.; Block, D.; Hau, D. D.; Wagner, J.; Miniaci, J.; Clements, M.; Gebremedhin, M.; Guo, N.; Zhang, Y.; Duggan, G. E.; Macinnis, G. D.; Weljie, A. M.; Dowlatabadi, R.; Bamforth, F.; Clive, D.; Greiner, R.; Li, L.; Marrie, T.; Sykes, B. D.; Vogel, H. J.; Querengesser, L. HMDB: the Human Metabolome Database Nucleic Acids Res. 2007, 35 (Database issue) D521-D526
118. Chagoyen, M.; Pazos, F. Tools for the functional interpretation of metabolomic experiments Briefings Bioinf. 2013, 14 (6) 737-744
119. Mendes, P. Emerging bioinformatics for the metabolome Briefings Bioinf. 2002, 3 (2) 134-145
120. Frolkis, A.; Knox, C.; Lim, E.; Jewison, T.; Law, V.; Hau, D. D.; Liu, P.; Gautam, B.; Ly, S.; Guo, A. C.; Xia, J.; Liang, Y.; Shrivastava, S.; Wishart, D. S. SMPDB: The Small Molecule Pathway Database Nucleic Acids Res. 2010, 38 (Database issue) D480-D487
121. Caspi, R.; Altman, T.; Dale, J. M.; Dreher, K.; Fulcher, C. A.; Gilham, F.; Kaipa, P.; Karthikeyan, A. S.; Kothari, A.; Krummenacker, M.; Latendresse, M.; Mueller, L. A.; Paley, S.; Popescu, L.; Pujar, A.; Shearer, A. G.; Zhang, P.; Karp, P. D. The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases Nucleic Acids Res. 2010, 38 (Database issue) D473-D479
122. Croft, D.; O'Kelly, G.; Wu, G.; Haw, R.; Gillespie, M.; Matthews, L.; Caudy, M.; Garapati, P.; Gopinath, G.; Jassal, B.; Jupe, S.; Kalatskaya, I.; Mahajan, S.; May, B.; Ndegwa, N.; Schmidt, E.; Shamovsky, V.; Yung, C.; Birney, E.; Hermjakob, H.; D'Eustachio, P.; Stein, L. Reactome: a database of reactions, pathways and biological processes Nucleic Acids Res. 2011, 39 (Database issue) D691-D697
123. Junker, B. H.; Klukas, C.; Schreiber, F. VANTED: a system for advanced data analysis and visualization in the context of biological networks BMC Bioinf. 2006, 7, 109
124. Letunic, I.; Yamada, T.; Kanehisa, M.; Bork, P. iPath: interactive exploration of biochemical pathways and networks Trends Biochem. Sci. 2008, 33 (3) 101-103
125. Sreenivasaiah, P. K.; Rani, S.; Cayetano, J.; Arul, N.; Kim do, H. IPAVS: Integrated Pathway Resources, Analysis and Visualization System Nucleic Acids Res. 2012, 40 (Database issue) D803-D808
126. Xia, J.; Wishart, D. S. MetPA: a web-based metabolomics tool for pathway analysis and visualization Bioinformatics 2010, 26 (18) 2342-2344
127. Karnovsky, A.; Weymouth, T.; Hull, T.; Tarcea, V. G.; Scardoni, G.; Laudanna, C.; Sartor, M. A.; Stringer, K. A.; Jagadish, H. V.; Burant, C.; Athey, B.; Omenn, G. S. Metscape 2 bioinformatics tool for the analysis and visualization of metabolomics and gene expression data Bioinformatics 2012, 28 (3) 373-380
128. Xia, J.; Wishart, D. S. MSEA: a web-based tool to identify biologically meaningful patterns in quantitative metabolomic data Nucleic Acids Res. 2010, 38 (Web Server issue) W71-W77
129. Kankainen, M.; Gopalacharyulu, P.; Holm, L.; Oresic, M. MPEA - metabolite pathway enrichment analysis Bioinformatics 2011, 27 (13) 1878-1879
130. Kamburov, A.; Cavill, R.; Ebbels, T. M.; Herwig, R.; Keun, H. C. Integrated pathway-level analysis of transcriptomics and metabolomics data with IMPaLA Bioinformatics 2011, 27 (20) 2917-2918
131. Chagoyen, M.; Pazos, F. MBRole: enrichment analysis of metabolomic data Bioinformatics 2011, 27 (5) 730-731
132. Srivastava, S.; Roy, R.; Singh, S.; Kumar, P.; Dalela, D.; Sankhwar, S. N.; Goel, A.; Sonkar, A. A. Taurine-a possible fingerprint biomarker in non-muscle invasive bladder cancer: A pilot study by 1 H NMR spectroscopy Cancer Biomark 2010, 6 (1) 11-20
133. Cao, M.; Zhao, L.; Chen, H.; Xue, W.; Lin, D. NMR-based metabolomic analysis of human bladder cancer Anal. Sci. 2012, 28 (5) 451-456
134. Bansal, N.; Gupta, A.; Mitash, N.; Shakya, P. S.; Mandhani, A.; Mahdi, A. A.; Sankhwar, S. N.; Mandal, S. K. Low-and High-Grade Bladder Cancer Determination via Human Serum-Based Metabolomics Approach J. Proteome Res. 2013, 12 (12) 5839-5850
135. Tripathi, P.; Somashekar, B. S.; Ponnusamy, M.; Gursky, A.; Dailey, S.; Kunju, P.; Lee, C. T.; Chinnaiyan, A. M.; Rajendiran, T. M.; Ramamoorthy, A. HR-MAS NMR Tissue Metabolomic Signatures Cross-Validated by Mass Spectrometry Distinguish Bladder Cancer from Benign Disease J. Proteome Res. 2013, 12 (7) 3519-3528
136. Willis, C. M.; Church, S. M.; Guest, C. M.; Cook, W. A.; McCarthy, N.; Bransbury, A. J.; Church, M. R.; Church, J. C. Olfactory detection of human bladder cancer by dogs: proof of principle study BMJ [Br. Med. J.] 2004, 329 (7468) 712
137. Jobu, K.; Sun, C.; Yoshioka, S.; Yokota, J.; Onogawa, M.; Kawada, C.; Inoue, K.; Shuin, T.; Sendo, T.; Miyamura, M. Metabolomics study on the biochemical profiles of odor elements in urine of human with bladder cancer Biol. Pharm. Bull. 2012, 35 (4) 639-642
138. Mondello, L.; Tranchida, P. Q.; Dugo, P.; Dugo, G. Comprehensive two-dimensional gas chromatography-mass spectrometry: A review Mass Spectrom. Rev. 2008, 27 (2) 101-124
139. Li, X.; Xu, Z.; Lu, X.; Yang, X.; Yin, P.; Kong, H.; Yu, Y.; Xu, G. Comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry for metabonomics: Biomarker discovery for diabetes mellitus Anal. Chim. Acta 2009, 633 (2) 257-262
140. Pierce, K. M.; Hoggard, J. C.; Mohler, R. E.; Synovec, R. E. Recent advancements in comprehensive two-dimensional separations with chemometrics J. Chromatogr., A 2008, 1184 (1) 341-352
141. Issaq, H. J.; Nativ, O.; Waybright, T.; Luke, B.; Veenstra, T. D.; Issaq, E. J.; Kravstov, A.; Mullerad, M. Detection of bladder cancer in human urine by metabolomic profiling using high performance liquid chromatography/mass spectrometry J. Urol. 2008, 179 (6) 2422-2426
142. Cubbon, S.; Bradbury, T.; Wilson, J.; Thomas-Oates, J. Hydrophilic interaction chromatography for mass spectrometric metabonomic studies of urine Anal. Chem. 2007, 79 (23) 8911-8918
143. Huang, Z.; Lin, L.; Gao, Y.; Chen, Y.; Yan, X.; Xing, J.; Hang, W. Bladder cancer determination via two urinary metabolites: a biomarker pattern approach Mol. Cell. Proteomics 2011, 10 (10) M111.007922
144. Huang, Z.; Chen, Y.; Hang, W.; Gao, Y.; Lin, L.; Li, D. Y.; Xing, J.; Yan, X. Holistic metabonomic profiling of urine affords potential early diagnosis for bladder and kidney cancers Metabolomics 2013, 9 (1) 119-129
145. Jin, X.; Yun, S. J.; Jeong, P.; Kim, I. Y.; Kim, W.-J.; Park, S. Diagnosis of bladder cancer and prediction of survival by urinary metabolomics Oncotarget 2014, 5 (6) 1635-1645
146. Alberice, J. V.; Amaral, A. F.; Armitage, E. G.; Lorente, J. A.; Algaba, F.; Carrilho, E.; Márquez, M.; García, A.; Malats, N.; Barbas, C. Searching for urine biomarkers of bladder cancer recurrence using a liquid chromatography-mass spectrometry and capillary electrophoresis-mass spectrometry metabolomics approach J. Chromatogr., A 2013, 1318, 163-170
147. Putluri, N.; Shojaie, A.; Vasu, V. T.; Vareed, S. K.; Nalluri, S.; Putluri, V.; Thangjam, G. S.; Panzitt, K.; Tallman, C. T.; Butler, C. Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression Cancer Res. 2011, 71 (24) 7376-7386
148. Rhodes, D. R.; Kalyana-Sundaram, S.; Tomlins, S. A.; Mahavisno, V.; Kasper, N.; Varambally, R.; Barrette, T. R.; Ghosh, D.; Varambally, S.; Chinnaiyan, A. M. Molecular concepts analysis links tumors, pathways, mechanisms, and drugs Neoplasia 2007, 9 (5) 443-454
149. Pendyala, L.; Velagapudi, S.; Toth, K.; Zdanowicz, J.; Glaves, D.; Slocum, H.; Perez, R.; Huben, R.; Creaven, P. J.; Raghavan, D. Translational studies of glutathione in bladder cancer cell lines and human specimens Clin. Cancer Res. 1997, 3 (5) 793-798
150. Giralt, M.; Lafuente, A.; Pujol, F.; Mallol, J. Enhanced glutathione S-transferase activity and glutathione content in human bladder cancer. Followup study: influence of smoking J. Urol. 1993, 149 (6) 1452-1454
151. Toyokuni, S.; Okamoto, K.; Yodoi, J.; Hiai, H. Persistent oxidative stress in cancer FEBS Lett. 1995, 358 (1) 1-3
152. Hileman, E. O.; Liu, J.; Albitar, M.; Keating, M. J.; Huang, P. Intrinsic oxidative stress in cancer cells: a biochemical basis for therapeutic selectivity Cancer Chemother. Pharmacol. 2004, 53 (3) 209-219
153. Behrend, L.; Henderson, G.; Zwacka, R. Reactive oxygen species in oncogenic transformation Biochem. Soc. Trans. 2003, 31 (Pt 6) 1441-1444
154. Meister, A.; Anderson, M. E. Glutathione Annu. Rev. Biochem. 1983, 52 (1) 711-760
155. Pelicano, H.; Carney, D.; Huang, P. ROS stress in cancer cells and therapeutic implications. Drug Resist Updates 2004, 7 (2) 97-110
156. Zhang, K.; Mack, P.; Wong, K. Glutathione-related mechanisms in cellular resistance to anticancer drugs Int. J. Oncol. 1998, 12 (4) 871-953
157. Shen, H.; Kauvar, L.; Tew, K. D. Importance of glutathione and associated enzymes in drug response Oncol. Res. 1996, 9 (6-7) 295-302
158. Gatenby, R. A.; Gillies, R. J. Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 2004, 4 (11) 891-899
159. Warburg, O. H.; Kaiser Wilhelm-Institut für Biologie (Berlin). über den Stoffwechsel der Tumoren; Springer: Berlin, 1926.
160. Semenza, G. L.; Artemov, D.; Bedi, A.; Bhujwalla, Z.; Chiles, K.; Feldser, D.; Laughner, E.; Ravi, R.; Simons, J.; Taghavi, P. The Metabolism of Tumours: 70 Years Later. In The Tumour Microenvironment: Causes and Consequences of Hypoxia and Acidity; Novartis Foundation Symposium 240; Goode, J.; Chadwick, D., Eds.; Wiley: New York, 2001; pp 251-264.
161. Zheng, Y.-F.; Kong, H.-W.; Xiong, J.-H.; Lv, S.; Xu, G.-W. Clinical significance and prognostic value of urinary nucleosides in breast cancer patients Clin. Biochem. 2005, 38 (1) 24-30
162. La, S.; Cho, J.; Kim, J.-H.; Kim, K.-R. Capillary electrophoretic profiling and pattern recognition analysis of urinary nucleosides from thyroid cancer patients Anal. Chim. Acta 2003, 486 (2) 171-182
163. Feng, B.; Zheng, M. H.; Zheng, Y. F.; Lu, A. G.; Li, J. W.; Wang, M. L.; Ma, J. J.; Xu, G. W.; Liu, B. Y.; Zhu, Z. G. Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring J. Gastroenterol. Hepatol. 2005, 20 (12) 1913-1919
164. Zhao, R.; Xu, G.; Yue, B.; Liebich, H.; Zhang, Y. Artificial neural network classification based on capillary electrophoresis of urinary nucleosides for the clinical diagnosis of tumors J. Chromatogr., A 1998, 828 (1) 489-496
165. Schramm, G.; Surmann, E.-M.; Wiesberg, S.; Oswald, M.; Reinelt, G.; Eils, R.; König, R. Analyzing the regulation of metabolic pathways in human breast cancer BMC Med. Genomics 2010, 3 (1) 39
166. Denkert, C.; Budczies, J.; Weichert, W.; Wohlgemuth, G.; Scholz, M.; Kind, T.; Niesporek, S.; Noske, A.; Buckendahl, A.; Dietel, M. Metabolite profiling of human colon carcinoma-deregulation of TCA cycle and amino acid turnover Mol. Cancer 2008, 7 (1) 72
167. Wu, H.; Xue, R.; Dong, L.; Liu, T.; Deng, C.; Zeng, H.; Shen, X. Metabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography/mass spectrometry Anal. Chim. Acta 2009, 648 (1) 98-104
168. Nakano, K.; Nakao, T.; Schram, K. H.; Hammargren, W. M.; McClure, T. D.; Katz, M.; Petersen, E. Urinary excretion of modified nucleosides as biological marker of RNA turnover in patients with cancer and AIDS Clin. Chim. Acta 1993, 218 (2) 169-183
169. Chung, K. T.; Gadupudi, G. S. Possible roles of excess tryptophan metabolites in cancer Environ. Mol. Mutagen. 2011, 52 (2) 81-104
170. Opitz, C. A.; Litzenburger, U. M.; Sahm, F.; Ott, M.; Tritschler, I.; Trump, S.; Schumacher, T.; Jestaedt, L.; Schrenk, D.; Weller, M. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor Nature 2011, 478 (7368) 197-203
171. Peluso, G.; Nicolai, R.; Reda, E.; Benatti, P.; Barbarisi, A.; Calvani, M. Cancer and anticancer therapy-induced modifications on metabolism mediated by carnitine system J. Cell. Physiol. 2000, 182 (3) 339-350
172. Anghileri, L. J.; Crone-Escanye, M.-C.; Thouvenot, P.; Brunotte, F.; Robert, J. Mechanisms of gallium-67 accumulation by tumors: Role of cell membrane permeability J. Nucl. Med. 1988, 29 (5) 663-668
173. Mycielska, M. E.; Patel, A.; Rizaner, N.; Mazurek, M. P.; Keun, H.; Patel, A.; Ganapathy, V.; Djamgoz, M. Citrate transport and metabolism in mammalian cells Bioessays 2009, 31 (1) 10-20
174. Rosado, J. O.; Salvador, M.; Bonatto, D. Importance of the trans-sulfuration pathway in cancer prevention and promotion Mol. Cell. Biochem. 2007, 301 (1-2) 1-12
175. Redmond, H. P.; Stapleton, P.; Neary, P.; Bouchier-Hayes, D. Immunonutrition: the role of taurine Nutrition 1998, 14 (7) 599-604
176. Griffin, J. L.; Shockcor, J. P. Metabolic profiles of cancer cells Nat. Rev. Cancer 2004, 4 (7) 551-561
177. Delaney, J.; Neville, W. A.; Swain, A.; Miles, A.; Leonard, M. S.; Waterfield, C. J. Phenylacetylglycine, a putative biomarker of phospholipidosis: its origins and relevance to phospholipid accumulation using amiodarone treated rats as a model Biomarkers 2004, 9 (3) 271-290
178. Kasuya, F.; Yamaoka, Y.; Osawa, E.; Igarashi, K.; Fukui, M. Difference of the liver and kidney in glycine conjugation of ortho-substituted benzoic acids Chem.-Biol. Interact. 2000, 125 (1) 39-50
179. Carrola, J.; Rocha, C. u. M.; Barros, A. n. S.; Gil, A. M.; Goodfellow, B. J.; Carreira, I. M.; Bernardo, J. o.; Gomes, A.; Sousa, V.; Carvalho, L. Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine J. Proteome Res. 2010, 10 (1) 221-230
180. De Vries, A.; Alexander, B.; Quamo, Y. Studies on amino acid metabolism. III. Plasma glycine concentration and hippuric acid formation following the ingestion of benzoate J. Clin. Invest. 1948, 27 (5) 665-668
181. Duydu, Y.; Süzen, S.; Erdem, N.; Uysal, H.; Vural, N. Validation of hippuric acid as a biomarker of toluene exposure Bull. Environ. Contam. Toxicol. 1999, 63 (1) 1-8
182. He, J. C.; Chuang, P. Y.; Ma'Ayan, A.; Iyengar, R. Systems biology of kidney diseases Kidney Int. 2012, 81 (1) 22-39
183. Xia, J.; Broadhurst, D. I.; Wilson, M.; Wishart, D. S. Translational biomarker discovery in clinical metabolomics: an introductory tutorial Metabolomics 2013, 9 (2) 280-299
184. Monteiro, M.; Carvalho, M.; Bastos, M.; Guedes de Pinho, P. Metabolomics analysis for biomarker discovery: advances and challenges Curr. Med. Chem. 2013, 20 (2) 257-271
185. Weiss, R. H.; Kim, K. Metabolomics in the study of kidney diseases Nat. Rev. Nephrol. 2012, 8 (1) 22-33
186. Alberg, A. J.; Kouzis, A.; Genkinger, J. M.; Gallicchio, L.; Burke, A. E.; Hoffman, S. C.; Diener-West, M.; Helzlsouer, K. J.; Comstock, G. W. A prospective cohort study of bladder cancer risk in relation to active cigarette smoking and household exposure to secondhand cigarette smoke Am. J. Epidemiol. 2007, 165 (6) 660-666
187. Augustine, A.; Hebert, J. R.; Kabat, G. C.; Wynder, E. L. Bladder cancer in relation to cigarette smoking Cancer Res. 1988, 48 (15) 4405-4408
188. Koutros, S.; Silverman, D. T.; Baris, D.; Zahm, S. H.; Morton, L. M.; Colt, J. S.; Hein, D. W.; Moore, L. E.; Johnson, A.; Schwenn, M.; Cherala, S.; Schned, A.; Doll, M. A.; Rothman, N.; Karagas, M. R. Hair dye use and risk of bladder cancer in the New England bladder cancer study Int. J. Cancer 2011, 129 (12) 2894-2904
189. Anton-Culver, H.; Lee-Feldstein, A.; Taylor, T. H. Occupation and bladder cancer risk Am. J. Epidemiol. 1992, 136 (1) 89-94
190. Jacobsen, U. P.; Nielsen, H. B.; Hildebrand, F.; Raes, J.; Sicheritz-Ponten, T.; Kouskoumvekaki, I.; Panagiotou, G. The chemical interactome space between the human host and the genetically defined gut metabotypes ISME J. 2013, 7 (4) 730-742
191. Nicholson, J. K.; Holmes, E.; Kinross, J.; Burcelin, R.; Gibson, G.; Jia, W.; Pettersson, S. Host-gut microbiota metabolic interactions Science 2012, 336 (6086) 1262-1267
192. Holmes, E.; Loo, R. L.; Stamler, J.; Bictash, M.; Yap, I. K.; Chan, Q.; Ebbels, T.; De Iorio, M.; Brown, I. J.; Veselkov, K. A.; Daviglus, M. L.; Kesteloot, H.; Ueshima, H.; Zhao, L.; Nicholson, J. K.; Elliott, P. Human metabolic phenotype diversity and its association with diet and blood pressure Nature 2008, 453 (7193) 396-400
193. Balog, J.; Sasi-Szabo, L.; Kinross, J.; Lewis, M. R.; Muirhead, L. J.; Veselkov, K.; Mirnezami, R.; Dezso, B.; Damjanovich, L.; Darzi, A.; Nicholson, J. K.; Takats, Z. Intraoperative tissue identification using rapid evaporative ionization mass spectrometry Sci. Transl. Med. 2013, 5 (194) 194ra93
194. Dettmer, K.; Aronov, P. A.; Hammock, B. D. Mass spectrometry-based metabolomics Mass Spectrom. Rev. 2007, 26 (1) 51-78
195. Garcia-Perez, I.; Vallejo, M.; Garcia, A.; Legido-Quigley, C.; Barbas, C. Metabolic fingerprinting with capillary electrophoresis J. Chromatogr., A 2008, 1204 (2) 130-139
196. Kell, D. B.; Brown, M.; Davey, H. M.; Dunn, W. B.; Spasic, I.; Oliver, S. G. Metabolic footprinting and systems biology: the medium is the message Nat. Rev. Microbiol. 2005, 3 (7) 557-565